Literature DB >> 15920155

Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.

Jamie Morrison1, Donald B Palmer, Stephen Cobbold, Terence Partridge, George Bou-Gharios.   

Abstract

Duchenne muscular dystrophy was initially described as a myosclerosis because of the conspicuous progression of interstitial fibrosis. Using the mdx mouse homologue, we have shown previously that the accumulation of intramuscular collagen is profoundly influenced by the presence or absence of T lymphocytes. Here we have used thymectomy and antibody depletion to examine the effect of ablating CD4 or CD8 or both subsets of T lymphocytes on skeletal muscle fibrosis in mdx and C57BL10 (wild-type) mice. Depletion of either or both subsets at 4 weeks of age did not influence fibrosis in mdx mice, as determined by measuring hydroxyproline levels and collagen deposition in diaphragm. Additionally, expression of transforming growth factor-beta1, which is implicated in collagen deposition, either decreased (mdx mice) or increased (C57BL/10 mice) after double CD4/8 depletion. Our data suggest that depletion of lymphoid cells may affect the tight regulatory control of transforming growth factor-beta1, with possible pleiotropic effects, and more importantly, that the fibrotic process is self-sustaining from a very early stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920155      PMCID: PMC1602408          DOI: 10.1016/S0002-9440(10)62480-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Effect of CD4(+) and CD8(+) cell depletion on wound healing.

Authors:  P A Davis; D J Corless; R Aspinall; C Wastell
Journal:  Br J Surg       Date:  2001-02       Impact factor: 6.939

Review 2.  TGF-beta and fibrosis.

Authors:  M H Branton; J B Kopp
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

3.  Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.

Authors:  M J Spencer; E Montecino-Rodriguez; K Dorshkind; J G Tidball
Journal:  Clin Immunol       Date:  2001-02       Impact factor: 3.969

Review 4.  T and B memory cells.

Authors:  J Sprent
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

5.  Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy.

Authors:  M Ishitobi; K Haginoya; Y Zhao; A Ohnuma; J Minato; T Yanagisawa; M Tanabu; M Kikuchi; K Iinuma
Journal:  Neuroreport       Date:  2000-12-18       Impact factor: 1.837

6.  Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.

Authors:  A Ahmad; M Brinson; B L Hodges; J S Chamberlain; A Amalfitano
Journal:  Hum Mol Genet       Date:  2000-10-12       Impact factor: 6.150

7.  Induction of skin fibrosis and autoantibodies by infusion of immunocompetent cells from tight skin mice into C57BL/6 Pa/Pa mice.

Authors:  R G Phelps; C Daian; S Shibata; R Fleischmajer; C A Bona
Journal:  J Autoimmun       Date:  1993-12       Impact factor: 7.094

8.  The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.

Authors:  H H Stedman; H L Sweeney; J B Shrager; H C Maguire; R A Panettieri; B Petrof; M Narusawa; J M Leferovich; J T Sladky; A M Kelly
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

9.  A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice.

Authors:  V A Wallace; S Kondo; T Kono; Z Xing; E Timms; C Furlonger; E Keystone; J Gauldie; D N Sauder; T W Mak
Journal:  Eur J Immunol       Date:  1994-06       Impact factor: 5.532

10.  mdx mice show progressive weakness and muscle deterioration with age.

Authors:  C Pastoret; A Sebille
Journal:  J Neurol Sci       Date:  1995-04       Impact factor: 3.181

View more
  18 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.

Authors:  Saurabh Dahiya; Srikanth Givvimani; Shephali Bhatnagar; Natia Qipshidze; Suresh C Tyagi; Ashok Kumar
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

3.  Fetal microchimeric cells in a fetus-treats-its-mother paradigm do not contribute to dystrophin production in serially parous mdx females.

Authors:  Elke Jane Seppanen; Samantha Susan Hodgson; Kiarash Khosrotehrani; George Bou-Gharios; Nicholas M Fisk
Journal:  Stem Cells Dev       Date:  2012-08-06       Impact factor: 3.272

4.  Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.

Authors:  Luca Bello; Kevin M Flanigan; Robert B Weiss; Pietro Spitali; Annemieke Aartsma-Rus; Francesco Muntoni; Irina Zaharieva; Alessandra Ferlini; Eugenio Mercuri; Sylvie Tuffery-Giraud; Mireille Claustres; Volker Straub; Hanns Lochmüller; Andrea Barp; Sara Vianello; Elena Pegoraro; Jaya Punetha; Heather Gordish-Dressman; Mamta Giri; Craig M McDonald; Eric P Hoffman
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

Review 5.  Targeting fibrosis in Duchenne muscular dystrophy.

Authors:  Lan Zhou; Haiyan Lu
Journal:  J Neuropathol Exp Neurol       Date:  2010-08       Impact factor: 3.685

6.  A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis.

Authors:  Gustavo A Nader; Maryam Dastmalchi; Helene Alexanderson; Cecilia Grundtman; Ramkishore Gernapudi; Mona Esbjörnsson; Zuyi Wang; Johan Rönnelid; Eric P Hoffman; Kanneboyina Nagaraju; Ingrid E Lundberg
Journal:  Mol Med       Date:  2010-08-16       Impact factor: 6.354

7.  Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Maria C Jordan; Tomomi Gotoh; Wayne W Grody; Kenneth P Roos; James G Tidball
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

Review 8.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

9.  Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.

Authors:  Hong Li; Ashwani Mittal; Denys Y Makonchuk; Shephali Bhatnagar; Ashok Kumar
Journal:  Hum Mol Genet       Date:  2009-04-28       Impact factor: 6.150

10.  Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Sophie Sokolow; Jamie J Lee; Kyu H Myung; S Armando Villalta; James G Tidball
Journal:  Hum Mol Genet       Date:  2008-04-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.